{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T06:49:59Z","timestamp":1764053399660,"version":"build-2065373602"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinics and Research in Hepatology and Gastroenterology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/j.clinre.2015.05.008","type":"journal-article","created":{"date-parts":[[2015,7,17]],"date-time":"2015-07-17T22:07:04Z","timestamp":1437170824000},"page":"S7-S11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"special_numbering":"S1","title":["Combination therapy: New hope for alcoholic hepatitis?"],"prefix":"10.1016","volume":"39","author":[{"given":"Bin","family":"Gao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vijay H.","family":"Shah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinre.2015.05.008_bib0225","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1053\/j.gastro.2011.09.002","article-title":"Alcoholic liver disease: pathogenesis and new therapeutic targets","volume":"141","author":"Gao","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2015.05.008_bib0230","doi-asserted-by":"crossref","first-page":"2758","DOI":"10.1056\/NEJMra0805786","article-title":"Alcoholic hepatitis","volume":"360","author":"Lucey","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2015.05.008_bib0235","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cgh.2013.06.013","article-title":"Alcoholic hepatitis: current challenges and future directions","volume":"12","author":"Singal","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2015.05.008_bib0240","doi-asserted-by":"crossref","first-page":"65e3","DOI":"10.1016\/j.cgh.2011.09.011","article-title":"Acute kidney injury is an early predictor of mortality for patients with alcoholic hepatitis","volume":"10","author":"Altamirano","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.clinre.2015.05.008_bib0245","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1053\/j.gastro.2009.04.062","article-title":"Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor","volume":"137","author":"Louvet","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2015.05.008_bib0250","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1136\/bmj.2.5260.1113","article-title":"Acute alcoholic hepatitis","volume":"2","author":"Beckett","year":"1961","journal-title":"Br Med JS"},{"key":"10.1016\/j.clinre.2015.05.008_bib0255","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1053\/j.gastro.2014.01.018","article-title":"A histologic scoring system for prognosis of patients with alcoholic hepatitis","volume":"146","author":"Altamirano","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2015.05.008_bib0260","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cld.2004.11.002","article-title":"Immunology of alcoholic liver disease","volume":"9","author":"Leevy","year":"2005","journal-title":"Clin Liver Dis"},{"key":"10.1016\/j.clinre.2015.05.008_bib0265","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1053\/j.gastro.2009.01.056","article-title":"Hepatic expression of CXC chemokines predicts portal hypertension and survival in patients with alcoholic hepatitis","volume":"136","author":"Dominguez","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2015.05.008_bib0270","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1146\/annurev-nutr-072610-145138","article-title":"Inflammation in alcoholic liver disease","volume":"32","author":"Wang","year":"2012","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/j.clinre.2015.05.008_bib0275","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1053\/j.gastro.2012.09.008","article-title":"Sterile inflammation in the liver","volume":"143","author":"Kubes","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2015.05.008_bib0280","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1053\/j.gastro.2014.01.020","article-title":"Interactions between the intestinal microbiome and liver diseases","volume":"146","author":"Schnabl","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2015.05.008_bib0285","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1053\/j.gastro.2014.10.042","article-title":"Gut\u2013liver axis in alcoholic liver disease","volume":"148","author":"Szabo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2015.05.008_bib0290","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1002\/hep.26419","article-title":"Chronic plus binge ethanol feeding synergistically induces neutrophil infiltration and liver injury in mice: a critical role for E-selectin","volume":"58","author":"Bertola","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2015.05.008_bib0295","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/hep.27383","article-title":"Osteopontin deficiency does not prevent but promotes alcoholic neutrophilic hepatitis in mice","volume":"61","author":"Lazaro","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2015.05.008_bib0300","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/nprot.2013.032","article-title":"Mouse model of chronic and binge ethanol feeding (the NIAAA model)","volume":"8","author":"Bertola","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1016\/j.clinre.2015.05.008_bib0305","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/0016-5085(79)90017-9","article-title":"Inhibition of hepatic regeneration in rats by acute and chronic ethanol intoxication","volume":"77","author":"Wands","year":"1979","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2015.05.008_bib0310","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.alcohol.2007.04.008","article-title":"Liver regeneration is suppressed in alcoholic cirrhosis: correlation with decreased STAT3 activation","volume":"41","author":"Horiguchi","year":"2007","journal-title":"Alcohol"},{"key":"10.1016\/j.clinre.2015.05.008_bib0315","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1002\/hep.25614","article-title":"Liver progenitor cell markers correlate with liver damage and predict short-term mortality in patients with alcoholic hepatitis","volume":"55","author":"Sancho-Bru","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2015.05.008_bib0320","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2014-308410","article-title":"Progenitor cell expansion and impaired hepatocyte regeneration in explanted livers from alcoholic hepatitis","author":"Dubuquoy","year":"2015","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2015.05.008_bib0325","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1136\/gut.2010.224097","article-title":"Corticosteroids improve short-term survival in patients with severe alcoholic hepatitis: meta-analysis of individual patient data","volume":"60","author":"Mathurin","year":"2011","journal-title":"Gut"},{"key":"10.1016\/j.clinre.2015.05.008_bib0330","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jhep.2009.12.045","article-title":"Glucocorticosteroids in acute alcoholic hepatitis: the evidence of a beneficial effect is getting even weaker","volume":"53","author":"Christensen","year":"2010","journal-title":"J Hepatol"},{"key":"10.1016\/j.clinre.2015.05.008_bib0335","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1002\/hep.26748","article-title":"Opposing effects of prednisolone treatment on T\/NKT cell- and hepatotoxin-mediated hepatitis in mice","volume":"39","author":"Kwon","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2015.05.008_bib0340","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1038\/nrd4176","article-title":"Therapeutic opportunities of the IL-22-IL-22R1 system","volume":"13","author":"Sabat","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.clinre.2015.05.008_bib0345","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/hep.23837","article-title":"Interleukin-22 treatment ameliorates alcoholic liver injury in a murine model of chronic-binge ethanol feeding: role of signal transducer and activator of transcription 3","volume":"52","author":"Ki","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2015.05.008_bib0350","doi-asserted-by":"crossref","first-page":"5510e1","DOI":"10.1371\/journal.pone.0055101","article-title":"Highest frequencies of interleukin-22-producing T helper cells in alcoholic hepatitis patients with a favourable short-term course","volume":"8","author":"Stoy","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.clinre.2015.05.008_bib0355","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1002\/hep.20184","article-title":"Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation","volume":"39","author":"Radaeva","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2015.05.008_bib0360","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00011-014-0727-3","article-title":"Role of interleukin-22 in liver diseases","volume":"63","author":"Pan","year":"2014","journal-title":"Inflamm Res"},{"key":"10.1016\/j.clinre.2015.05.008_bib0365","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/bph.12196","article-title":"IL-22 in tissue-protective therapy","volume":"169","author":"Muhl","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.clinre.2015.05.008_bib0370","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1002\/hep.25744","article-title":"Interleukin-22 induces hepatic stellate cell senescence and restricts liver fibrosis in mice","volume":"56","author":"Kong","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2015.05.008_bib0375","doi-asserted-by":"crossref","first-page":"765e1","DOI":"10.1053\/j.gastro.2012.05.049","article-title":"Interleukin-17 signaling in inflammatory Kupffer cells, and hepatic stellate cells exacerbates liver fibrosis in mice","volume":"143","author":"Meng","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2015.05.008_bib0380","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1002\/hep.26916","article-title":"Pathological functions of interleukin-22 in chronic liver inflammation and fibrosis with hepatitis B virus infection by promoting T helper 17 cell recruitment","volume":"59","author":"Zhao","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2015.05.008_bib0385","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1053\/j.gastro.2011.06.051","article-title":"A proinflammatory role for interleukin-22 in the immune response to hepatitis B virus","volume":"141","author":"Zhang","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2015.05.008_bib0390","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1053\/j.gastro.2012.03.044","article-title":"Interleukin-22 promotes proliferation of liver stem\/progenitor cells in mice and patients with chronic hepatitis B virus infection","volume":"143","author":"Feng","year":"2012","journal-title":"Gastroenterology"},{"issue":"4","key":"10.1016\/j.clinre.2015.05.008_bib0395","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/hep.27629","article-title":"Interleukin-22 and IL-22 binding protein (IL-22BP) regulate fibrosis and cirrhosis in hepatitis C virus and schistosome infections","volume":"61","author":"Sertorio","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.clinre.2015.05.008_bib0400","article-title":"Blockade of PD1 and TIM3 restores innate and adaptive immunity in patients with acute alcoholic hepatitis","author":"Markwick","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2015.05.008_bib0405","first-page":"213","article-title":"Role of IL-22 in microbial host defense","volume":"380","author":"Eidenschenk","year":"2014","journal-title":"Curr Top Microbiol Immunol"},{"key":"10.1016\/j.clinre.2015.05.008_bib0410","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1053\/gast.2000.20189","article-title":"Pentoxifylline improves short-term survival in severe acute alcoholic hepatitis: a double-blind, placebo-controlled trial","volume":"119","author":"Akriviadis","year":"2000","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2015.05.008_bib0415","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1681\/ASN.2013060611","article-title":"IL-22 ameliorates renal ischemia-reperfusion injury by targeting proximal tubule epithelium","volume":"25","author":"Xu","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.clinre.2015.05.008_bib0420","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1681\/ASN.2013050528","article-title":"Toll-like receptor 4-induced IL-22 accelerates kidney regeneration","volume":"25","author":"Kulkarni","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/j.clinre.2015.05.008_bib0425","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1056\/NEJMoa1101214","article-title":"Glucocorticoids plus N-acetylcysteine in severe alcoholic hepatitis","volume":"365","author":"Nguyen-Khac","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clinre.2015.05.008_bib0430","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.2013.276300","article-title":"Prednisolone with vs without pentoxifylline and survival of patients with severe alcoholic hepatitis: a randomized clinical trial","volume":"310","author":"Mathurin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.clinre.2015.05.008_bib0435","doi-asserted-by":"crossref","first-page":"574e1","DOI":"10.1053\/j.gastro.2013.05.042","article-title":"Efficacy and safety of the farnesoid X receptor agonist obeticholic acid in patients with type 2 diabetes and nonalcoholic fatty liver disease","volume":"145","author":"Mudaliar","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/j.clinre.2015.05.008_bib0440","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/hep.24339","article-title":"In vivo consequences of liver-specific interleukin-22 expression in mice: implications for human liver disease progression","volume":"54","author":"Park","year":"2011","journal-title":"Hepatology"}],"container-title":["Clinics and Research in Hepatology and Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740115001187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210740115001187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:21:56Z","timestamp":1761895316000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210740115001187"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9]]},"references-count":44,"alternative-id":["S2210740115001187"],"URL":"https:\/\/doi.org\/10.1016\/j.clinre.2015.05.008","relation":{},"ISSN":["2210-7401"],"issn-type":[{"type":"print","value":"2210-7401"}],"subject":[],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Combination therapy: New hope for alcoholic hepatitis?","name":"articletitle","label":"Article Title"},{"value":"Clinics and Research in Hepatology and Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinre.2015.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Masson SAS","name":"copyright","label":"Copyright"}]}}